Normal Tension Glaucoma: Risks, Diagnosis, and Treatment

Normal pressure can still be glaucoma

Normal tension glaucoma (NTG) is an open-angle glaucoma in which eye pressure may remain in the normal range while the optic nerve is damaged gradually. A normal pressure reading does not rule out glaucoma because diagnosis depends on optic-nerve damage and matching visual-field changes, not pressure alone.

Some clinical definitions describe NTG as optic-nerve damage with measured pressure consistently below 21 mmHg. Another describes the average pressure range as 10 to 21 mmHg. These figures describe pressure measurements, not your diagnosis. A single reading cannot settle whether your optic nerve is healthy.

The terms low-tension glaucoma and normal-pressure glaucoma can be misleading. The pressure is usually in the average range rather than truly low, and some people have higher readings between 2:00 AM and 6:00 AM. That is one reason an eye doctor may look at more than one pressure measurement.

NTG accounts for approximately one-third of open-angle glaucoma cases in the United States and up to 90% of glaucoma cases in certain Asian populations. Across population-based studies, NTG represented between 30% and 40% of patients diagnosed with a glaucomatous visual-field defect, including a reported U.S. proportion of 31.7%. These figures come from different populations and cannot estimate your personal risk.

The damage may appear closer to central vision

NTG and primary open-angle glaucoma both involve an open drainage angle, optic-nerve damage, and visual-field loss. The pattern can differ. Compared with primary open-angle glaucoma, NTG visual-field defects typically appear deeper, steeper, and closer to the center of vision.

NTG may also cause visual-field changes closer to central vision, more localized retinal nerve fiber layer defects, and more optic-disc hemorrhages than primary open-angle glaucoma. Visual-field loss can be greater than the optic-nerve appearance alone would suggest, so an eye doctor compares several findings rather than judging the pressure number by itself.

For you, the practical point is simple: a pressure reading in the usual range does not explain every part of the examination. The location and shape of visual-field changes help determine whether the nerve damage fits an NTG pattern.

The Collaborative Normal Tension Glaucoma Study reported that a 30% reduction in eye pressure can prevent visual-field progression in half of patients with documented progression or a threat to fixation. That result supports pressure reduction as part of management, but it does not mean every eye has the same target or response.

Your treatment plan depends on the pattern and pace of change in each eye. A pressure target is useful only when it is considered alongside the optic nerve, visual field, and other examination findings.

Factors linked with normal tension glaucoma

Possible contributors to NTG include blood-flow abnormalities and structural weakness in optic-nerve tissue. Vascular problems may also contribute, including impaired blood-flow regulation, obstructive sleep apnea, vasospastic disorders, and other conditions that may reduce blood flow to the optic nerve.

The reasons remain under study, and it is unclear whether finding or treating these conditions changes the disease course. A possible association does not show that a particular condition caused your optic-nerve damage.

Risk factors and associations include a family history of glaucoma, a thin cornea, myopia, migraine, low blood pressure, Japanese ancestry, and optic-nerve hemorrhages. Risk factors for primary open-angle glaucoma include low ocular perfusion pressure, type 2 diabetes, older age, and certain racial or ethnic backgrounds.

NTG tends to affect older patients than primary open-angle glaucoma, although a younger subset tends to be women. Japanese ancestry is an association, but reported estimates vary by study: NTG has been described in about two-thirds to 92% of Japanese patients with glaucoma. These figures may not apply to every population or individual.

Nocturnal low blood pressure has been associated with faster progression, but observational evidence does not prove that it causes progression. Excessive nighttime blood-pressure reduction was associated with greater odds of visual-field progression: 3.32 for systolic dipping and 2.09 for diastolic dipping.

Those figures describe associations in the studied groups, not a prediction for your eyes. Do not try to raise or lower your blood pressure without medical guidance.

A family history raises your risk but does not make NTG certain. If a parent, sibling, or another family member has glaucoma, arrange a comprehensive eye examination so an eye doctor can assess your optic nerves, visual fields, and pressure.

Vision changes can be gradual or easy to miss

NTG may cause gradual side-vision loss, trouble with contrast, patchy blind spots, bumping into objects, night-driving difficulty, or reading difficulty in advanced cases. Side vision can change slowly enough that you adapt without realizing it.

Possible changes include:

• Missing objects or people approaching from the side
• Difficulty seeing differences in shading or depth, especially in low light
• New or patchy areas of missing vision
• More difficulty driving at night
• Losing your place while reading in advanced disease

These signs do not identify the cause by themselves. They do give you a reason to arrange an eye examination.

NTG typically causes no eye pain, redness, or obvious symptoms. The absence of pain does not settle whether the optic nerve is healthy, so regular eye examinations matter, especially when you have a family history or notice a gradual change in vision.

Untreated NTG usually progresses slowly, but it can eventually affect central vision and daily activities. Changes in reading, driving, navigation, or recognizing objects deserve an eye examination rather than a guess about the cause.

The examination looks beyond one pressure reading

A glaucoma evaluation may include pressure measurement, gonioscopy, a dilated optic-nerve examination, optical coherence tomography (OCT), visual-field testing, and corneal-thickness measurement. Your doctor may measure eye pressure multiple times and sometimes at different times of day because one reading may not distinguish NTG from high-pressure glaucoma.

Gonioscopy checks the drainage angle to confirm that it is open. A careful optic-nerve examination through dilated pupils lets the doctor assess the nerve directly. Measuring corneal thickness helps assess glaucoma risk and interpret eye-pressure readings.

OCT and other imaging may measure the retinal nerve fiber layer, optic nerve head, and optic-nerve cupping. These images give the doctor structural information to compare over time.

A visual-field test maps your peripheral vision and blind spots by asking you to respond to small flashes of light in different locations. Repeating the test helps show whether the pattern is stable or progressing. Visual-field testing can also check for subtle changes near central vision, where NTG defects may appear.

A normal pressure reading during one office visit does not erase an abnormal optic-nerve or visual-field pattern. Pressure can remain in the usual 10 to 21 mmHg range while glaucoma is present, and your doctor may add measurements at different times of day to see whether pressure rises outside the clinic.

The full pattern matters more than any single test result. Ask what each test measures and which result your doctor will compare at a future visit.

Diagnosis depends on matching patterns

NTG diagnosis depends on a pattern of optic-nerve damage, usually supported by matching visual-field loss, rather than eye pressure alone. Your doctor compares the nerve examination, OCT or other images, pressure readings, corneal thickness, and visual-field results.

The comparison helps separate glaucoma from pressure readings that happen to fall in the average range. Visual-field testing checks for blind spots, including subtle changes near central vision, and helps monitor progressive loss.

Other glaucoma types can resemble NTG, including conditions with pressure fluctuations or spikes that a routine examination may not detect. This is why repeated testing and follow-up can matter even when the first pressure reading looks normal.

Atypical or one-sided optic-nerve findings may lead your doctor to recommend brain or optic-nerve imaging or a neuro-ophthalmic evaluation. One-sided optic-nerve damage deserves particular care because an eye doctor may need to look for causes other than glaucoma.

In one referral study, 80 of 98 patients, or 82%, had disease in both eyes. Among the 17 patients who received neuro-ophthalmic workup, 9, or 53%, had another identifiable cause of optic-nerve damage, including possible compressive optic neuropathy in 6 patients. Those figures describe a selected referral population, not everyone evaluated for NTG.

Rapid progression despite treatment should prompt reassessment of the diagnosis and evaluation for nonglaucomatous causes of vision loss. If your test results do not fit the expected pattern, ask what the doctor is checking and which findings will be followed at the next visit.

Treatment lowers pressure even when pressure is normal

NTG treatment still focuses on lowering eye pressure, even when the starting pressure is in the normal range. Lower pressure is the main modifiable treatment target identified for glaucoma, while possible blood-flow factors may require separate medical discussion.

Treatment may include:

• Medication to lower eye pressure
• Laser treatment when it is appropriate for the eye
• Surgery when medication and laser treatment do not reach the target pressure

The choice depends on the pressure pattern, optic-nerve damage, visual-field change, and how each eye responds.

Pressure-lowering medication options may include prostaglandin analogs, beta-blockers, alpha-2 agonists, carbonic anhydrase inhibitors, and miotic agents. Your eye doctor chooses among these options based on your pressure goal, examination findings, other medicines, and health conditions.

Use glaucoma medicines only as prescribed. Tell the prescribing clinician about side effects, missed doses, or difficulty following the schedule instead of stopping treatment on your own.

Treatment targets are individualized. Some experts use at least a 20% reduction as a guideline, while some eyes need pressures of 12 mmHg, 10 mmHg, or 8 mmHg. Those target values are examples from clinical discussion, not goals you should set without an eye examination.

In the Collaborative Normal Tension Glaucoma Study, pressure lowering slowed progression; the reported 5-year survival rate was 40% in the control arm and 80% in the treated arm. The study result supports active management, but it does not guarantee a particular result for your eyes.

Follow-up shows whether the plan is working

NTG follow-up compares your pressure, optic-nerve structure, and visual fields with earlier results. A lower pressure is useful only if the plan also fits the way your nerve and vision are changing. Repeated visual-field testing helps show whether the pattern is stable or progressing.

Follow-up may help your doctor decide whether to:

• Keep the current pressure target
• Adjust medication or another treatment
• Repeat testing when results are difficult to interpret
• Look for another cause when the pattern changes rapidly

Greater pressure reduction may prevent more progression, but pressure reduction does not prevent progression in every patient.

A study of NTG participants found that a 30% pressure reduction lowered the long-term risk of worsening from 35% to 12%. The comparison measures disease-worsening risk before and after pressure reduction in that study; it is not a promise about an individual eye.

Nearly 50% of untreated patients in one study did not progress over 5 to 7 years. That finding shows that NTG and the benefit of pressure lowering vary among patients, not that treatment is unnecessary for you.

A long-term study of 72 patients followed for 21.2 ± 1.1 years on average found that visual fields worsened at a mean rate of −0.28 ± 0.24 dB per year. A group average cannot predict the pace of change in your eyes.

A commonly used goal is to lower pressure by at least 20%, but the target is individualized. Some eyes may need a pressure of 12 mmHg, 10 mmHg, or 8 mmHg, so follow-up results help the doctor decide whether your target remains appropriate.

Do not change medicines without clinical guidance

Blood-pressure and glaucoma medicine changes require coordination between your clinicians. Do not change blood-pressure or glaucoma medicines on your own because excessive blood-pressure lowering can reduce ocular perfusion pressure, meaning the pressure that supports blood flow to the optic nerve.

Your eye doctor may suggest discussing a blood-pressure medicine adjustment with your primary-care doctor. Bring the names and doses of your medicines to eye visits so the clinicians can consider the full treatment picture.

Additional medical evaluation may be considered if NTG worsens despite pressure-lowering treatment. Clinicians may evaluate conditions such as Raynaud phenomenon or sleep apnea and may use a sleep study or 24-hour blood-pressure monitoring.

These tests are considered when the clinical pattern calls for them. They are not required for every person with NTG.

An eye doctor should consider associated conditions such as anemia, an abnormal heart rhythm, hypothyroidism, autoimmune disease, and migraine and address them when appropriate. Tell your eye doctor about these conditions because the medical review may add context to the pressure, optic-nerve, and visual-field findings.

Arrange an eye examination for concerning changes

A comprehensive eye examination is appropriate if a family member has glaucoma, even if your vision feels normal. NTG typically causes no pain, redness, or obvious early symptoms, and gradual side-vision changes can be easy to miss.

Arrange an examination if you notice:

• Gradual loss of side vision
• New or patchy blind spots
• Trouble with contrast
• Bumping into objects
• Difficulty driving at night
• Reading difficulty in advanced cases

Tell the eye doctor when the change began and whether it affects one eye or both. If vision changes suddenly or become markedly worse, contact a qualified eye-care professional or the responsible authority promptly for immediate qualified help rather than waiting for a routine appointment. Do not change blood-pressure or glaucoma medicines while waiting. When the urgency is unclear, make that prompt contact rather than guessing about the cause.

Rapid progression despite treatment should prompt your doctor to reassess the diagnosis and look for other causes of vision loss. Keep your follow-up visits and bring an updated list of your medicines, including blood-pressure medicines, so your clinicians can coordinate decisions.

Glaucoma affects about 3 million Americans, and an estimated half are not aware that they have it. The estimate concerns glaucoma in the United States as a whole, not NTG specifically. It supports paying attention to scheduled eye examinations rather than waiting for pain or obvious vision loss.

Choose your next step for eye evaluation

Your doctor may use the usual glaucoma tests and measure eye pressure at different times of day to check whether it stays in the average range. If you have symptoms, a family history, an abnormal test, or questions about treatment and follow-up, bring those concerns to an eye examination at Northwest Eye in Minnetonka.

A qualified eye doctor must decide which tests and treatment plan fit your eyes. Do not change blood-pressure or glaucoma medicines based on one pressure number. Use the examination to discuss what your results mean and what follow-up you need.

Questions to ask about normal tension glaucoma

Can one normal eye-pressure reading rule out normal tension glaucoma?

No. One pressure reading cannot rule out normal tension glaucoma because diagnosis depends on the pattern of optic-nerve damage and matching visual-field changes. Your eye doctor may repeat pressure measurements at different times of day, then compare them with OCT or other imaging, visual-field results, corneal thickness, and the optic-nerve examination.

Does a family history of glaucoma mean I will develop normal tension glaucoma?

No. A family history raises your risk but does not make normal tension glaucoma certain. If a parent, sibling, or another family member has glaucoma, arrange a comprehensive eye examination even if your vision feels normal, because this condition often causes no pain or obvious early symptoms.

Can blood-pressure medicine affect normal tension glaucoma?

It can matter if treatment lowers your blood pressure excessively, but do not change medication on your own. Lower systemic blood pressure can reduce blood flow support to the optic nerve. Your eye doctor may recommend discussing medication timing or dosage with your primary-care doctor, who should coordinate any adjustment.

What does one-sided optic-nerve damage mean in a normal tension glaucoma evaluation?

One-sided damage may lead your eye doctor to look for causes other than glaucoma. The evaluation may include brain or optic-nerve imaging or a neuro-ophthalmic assessment when findings are atypical, asymmetric, or suggest another cause. If disease progresses rapidly despite treatment, the diagnosis should be reassessed.